Instadose Pharma Corp. (INSD)
| Market Cap | 532.00 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -360.92K |
| Shares Out | 531.93M |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 300 |
| Average Volume | 9 |
| Open | n/a |
| Previous Close | 0.0011 |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | -828.79 |
| RSI | 0.43 |
| Earnings Date | n/a |
About Instadose Pharma
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada. [Read more]
Full Company ProfileNews
NOTICE For Investors In OTC: INSD: Update in Lawsuit against Instadose Pharma Corp. announced by Shareholders Foundation
San Diego, California--(Newsfile Corp. - December 6, 2022) - The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Instadose Pharma Co...
SHARFEHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. of Class Action Lawsuit and Upcoming Deadline - INSD; MZKR
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose", "Mikrocoze", or the "Compa...
FINAL DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - INSD, MZKR
New York, New York--(Newsfile Corp. - February 28, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ...
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Instadose Investors of a Lead Plaintiff Deadline of February 28, 2022
NEW YORK , Feb. 28, 2022 /PRNewswire/ -- Attention Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose") (OTC Other: INSD) shareholders: The Law Offices of Vincent Wong announce that a class acti...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 28, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inves...
Monday Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 25, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...
INSD SHAREHOLDER ALERT: Jakubowitz Law Reminds Instadose Shareholders of a Lead Plaintiff Deadline of February 28, 2022
NEW YORK , Feb. 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (...
SHARFEHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. of Class Action Lawsuit and Upcoming Deadline - INSD; MZKR
New York, New York--(Newsfile Corp. - February 24, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose", "Mikro...
INSD LAWSUIT ALERT: Levi & Korsinsky Notifies Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose" or the "Company") (OTC Other: INSD) of a class action secu...
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 28 Deadline in Securities Class Action - INSD, MZKR
New York, New York--(Newsfile Corp. - February 23, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ...
Deadline Monday Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 23, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 28, 2022 - (OTC Other: INSD)
NEW YORK , Feb. 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Instadose Pharma Corp. f/k/a Mikrocoze, Inc.. Shareholders who purchased shares of ...
INSD; MZKR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Shareholders of Class Action and Lead Deadline: February 28, 2022
New York, New York--(Newsfile Corp. - February 22, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikroco...
7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 21, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...
INSD INVESTOR NEWS: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action - INSD, MZKR
New York, New York--(Newsfile Corp. - February 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action - INSD, MZKR
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD, MZKR) b...
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...
INSD Investors Have Opportunity to Lead Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Securities Fraud Lawsuit
LOS ANGELES, Feb. 17, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit again...
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation
SAN DIEGO, Feb. 16, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on February 28, 2022, in the lawsuit that was filed for certain investors in OTC: INSD...
ROSEN, A TOP RANKED FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors to Secure Counsel Before Important February 28 Deadline in Securities Class Action - INSD, MZKR
New York, New York--(Newsfile Corp. - February 15, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ...
INSD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 28, 2022 in the Class Action Filed on Behalf of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Shareholders
NEW YORK, Feb. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC Other: ...
INSD Loss Alert: Rosen, Trusted and Top Ranked Investor Counsel, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INSD, MZKR
New York, New York--(Newsfile Corp. - February 10, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc....
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INSD, MZKR
NEW YORK, Feb. 9, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTCMKTS: INSD) (OT...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. of Class Action Lawsuit and Upcoming Deadline - INSD; MZKR
NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. ("Instadose", "Mikrocoze", or the "Compan...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) Investors
LOS ANGELES, Feb. 4, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired I...